NASDAQ:PRXL - PAREXEL International Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding PAREXEL International Co. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $88.08 0.00 (0.00 %) (As of 10/9/2017) Add Today's Range$88.08Now: $88.08▼$88.0850-Day Range$88.08MA: $88.08▼$88.0852-Week Range$51.16Now: $88.08▼$88.10VolumeN/AAverage Volume1.04 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries. Its segments include Clinical Research Services (CRS), PAREXEL Consulting Services (PC) and PAREXEL Informatics (PI). Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryLife Sciences Tools & Services SectorN/A Current SymbolNASDAQ:PRXL Previous Symbol CUSIP69946210 CIK799729 Webhttp://www.parexel.com/ Phone+1-781-4879900Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive PRXL News and Ratings via Email Sign-up to receive the latest news and ratings for PRXL and its competitors with MarketBeat's FREE daily newsletter. PAREXEL International (NASDAQ:PRXL) Frequently Asked Questions What is PAREXEL International's stock symbol? PAREXEL International trades on the NASDAQ under the ticker symbol "PRXL." Has PAREXEL International been receiving favorable news coverage? Press coverage about PRXL stock has been trending somewhat negative on Sunday, according to InfoTrie. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. PAREXEL International earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave media headlines about the medical research company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for PAREXEL International. Who are some of PAREXEL International's key competitors? Some companies that are related to PAREXEL International include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), BIO-TECHNE (TECH), Bruker (BRKR), Charles River Laboratories Intl. (CRL), Cambrex (CBM), Luminex (LMNX), Pacific Biosciences of California (PACB), Fluidigm (FLDM) and Harvard Bioscience (HBIO). What other stocks do shareholders of PAREXEL International own? Based on aggregate information from My MarketBeat watchlists, some companies that other PAREXEL International investors own include Celgene (CELG), Universal Display (OLED), Baidu (BIDU), Gilead Sciences (GILD), Icon (ICLR), Intel (INTC), Netflix (NFLX), Skyworks Solutions (SWKS), Allergan (AGN) and Royal Bank of Canada (RY). Who are PAREXEL International's key executives? PAREXEL International's management team includes the folowing people: Josef H. von Rickenbach, Chairman of the Board, Chief Executive OfficerMark A. Goldberg M.D., President, Chief Operating OfficerSimon Harford, Chief Financial Officer, Senior Vice President, Bio & Compensation - Xavier AB Flinois, President - PAREXEL InformaticsMichelle Graham, Chief Human Resource Officer, Senior Vice PresidentSybrand Pretorius M.D., Senior Vice President, Chief Scientific OfficerDouglas Alexander Batt, Senior Vice President, General Counsel, SecretaryRoland Andersson Ph.d., Senior Vice President - Clinical Research ServicesChristian Dreger Ph.D., Senior Vice President - Parexel Access and Parexel Consulting, Bio & Compensation - David J. Godwin, Senior Vice President-Global Business What is PAREXEL International's stock price today? One share of PRXL stock can currently be purchased for approximately $88.08. What is PAREXEL International's official website? The official website for PAREXEL International is http://www.parexel.com/. How can I contact PAREXEL International? PAREXEL International's mailing address is 195 West St, WALTHAM, MA 02451-1111, United States. The medical research company can be reached via phone at +1-781-4879900. MarketBeat Community Rating for PAREXEL International (NASDAQ PRXL)Community Ranking: 2.2 out of 5 ( )Outperform Votes: 426 (Vote Outperform)Underperform Votes: 549 (Vote Underperform)Total Votes: 975MarketBeat's community ratings are surveys of what our community members think about PAREXEL International and other stocks. Vote "Outperform" if you believe PRXL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRXL will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/8/2019 by MarketBeat.com StaffFeatured Article: Basic Economics creates winners and losers
